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INTRODUCTION: Cell based strategies envision 
promising insights for tendon therapies due to the 
naturally limited cellularity and regeneration of 
these tissues. Human stem cells from the stromal 
vascular fraction of adipose tissue (hASCs) have 
shown their tenogenic potential for tendon 
strategies[1]. However, the heterogeneous 
populations within the hASCs pool may hinder 
their use in specific applications. Tenomodulin 
(TNMD) has been recognized as an important 
marker of tendon progenitor cells[2], thus herein 
we hypothesized that TNMD positive (TNMD+) 
cells are more prone to differentiate into tendon-
like cells. Therefore, a distinct TNMD+ 
subpopulation was isolated from hASCs by 
immunomagnetic cell separation[3]. Subsequently, 
the tenogenic differentiation capacity of TNMD+ 
cells was evaluated (towards the heterogenous 
hASCs population obtained from the SVF) in the 
presence of growth factors (GFs) associated to 
development, growth and healing of tendon 
tissue[1]. Cell response to biochemical stimuli was 
studied analysing cell morphology, tendon-related 
markers expression, and extracellular matrix 
(ECM) formation. 
METHODS: TNMD+ cells were sorted using 
Dynabeads® M-450 Epoxy (Invitrogen) coupled 
with TNMD antibody (Santa Cruz Biotech). Cells 
isolated without antibody coupling were 
considered the control population (CTR). 
Tenogenic differentiation capacity of both 
TNMD+ and CTR populations was evaluated for 
up to 28 days in α-medium or with: EGF, bFGF, 
PDGF-BB or TGF-β1. The time-related effects of 
GFs supplementation on the expression of tendon-
related markers was evaluated by RT-PCR and 
flow cytometry, while the ability of cells to 
synthetize a Collagen I and III ECM was analysed 
by immunocytochemistry. 
RESULTS: A TNMD+ subpopulation was 
successfully obtained by immunomagnetic 
separation as demonstrated by TNMD deposition 
in sorted cells in comparison to CTR cells (Fig.1). 
TNMD+ cells showed enhanced genetic expression 
of tendon markers, namely SCX, TNMD, and 
DCN as well as Col I and III over CTR cells for up 
to 28 days. 
 
Fig. 1: Micrographs of hASCs: CTR cells (A) and 
TNMD+ cells (B) 3 days after of immunomagnetic 
isolation; TNMD immunolocation (green) in CTR 
(C) and TNMD+ cells (D). DAPI (blue) stains cell 
nuclei. 
SCX and TNMD protein expression by flow 
cytometry was also increased in TNMD+ cells. 
Although gene and protein expression were 
influenced by supplemented GFs with a tendency 
to increase the expression of tendon markers in 
TNMD+ cells, no evident differences between 
supplemented and α-medium were found.  
DISCUSSION & CONCLUSIONS: TNMD+ 
cells show a markedly positive tenogenic response 
in comparison to CTR cells. This response is 
supported by the enhanced genetic and protein 
expression of tendon markers. Thus, the TNMD+ 
subpopulation is predisposed towards tenogenic 
lineage and therefore can be used more efficiently 
as source of tendon progenitor cells. 
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